0000899243-20-018175.txt : 20200701
0000899243-20-018175.hdr.sgml : 20200701
20200701192823
ACCESSION NUMBER: 0000899243-20-018175
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200629
FILED AS OF DATE: 20200701
DATE AS OF CHANGE: 20200701
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CRANSTON MARY B
CENTRAL INDEX KEY: 0001104268
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37609
FILM NUMBER: 201006604
MAIL ADDRESS:
STREET 1: C/O VISA INC.
STREET 2: P.O. BOX 8999
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94128-8999
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MyoKardia, Inc.
CENTRAL INDEX KEY: 0001552451
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 455500552
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1000 SIERRA POINT PARKWAY
CITY: BRISBANE
STATE: CA
ZIP: 94005
BUSINESS PHONE: 650-741-0900
MAIL ADDRESS:
STREET 1: 1000 SIERRA POINT PARKWAY
CITY: BRISBANE
STATE: CA
ZIP: 94005
FORMER COMPANY:
FORMER CONFORMED NAME: MyoKardia Inc
DATE OF NAME CHANGE: 20120618
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-06-29
0
0001552451
MyoKardia, Inc.
MYOK
0001104268
CRANSTON MARY B
C/O MYOKARDIA, INC.
1000 SIERRA POINT PARKWAY
BRISBANE
CA
94005
1
0
0
0
Common Stock
2020-06-29
4
M
0
371
11.69
A
371
D
Common Stock
2020-06-29
4
S
0
371
98.6821
D
0
D
Common Stock
2020-06-30
4
M
0
21629
11.69
A
21629
D
Common Stock
2020-06-30
4
S
0
300
97.2547
D
21329
D
Common Stock
2020-06-30
4
S
0
21329
96.5905
D
0
D
Stock Option (Right to Buy)
11.69
2020-06-29
4
M
0
371
0.00
D
2026-04-10
Common Stock
371
21629
D
Stock Option (Right to Buy)
11.69
2020-06-30
4
M
0
21629
0.00
D
2026-04-10
Common Stock
21629
0
D
Represents the weighted average sale price of the shares sold ranging from $98.50 to $98.725 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the ranges set forth in footnotes 1 through 3.
Represents the weighted average sale price of the shares sold ranging from $97.247 to $97.27 per share.
Represents the weighted average sale price of the shares sold ranging from $96.24 to $97.236 per share.
The shares subject to the option vested in 48 equal monthly installments from April 11, 2016 to April 11, 2020.
/s/Cynthia J. Ladd, as Attorney-in-Fact
2020-07-01